BG Medicine Posts 45 Percent Rise in 2013 Revenues, Sharp Drop in Operating Expenses | GenomeWeb

BG Medicine this week reported a 7 percent increase year over year in revenues for the fourth quarter.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2013 totaled $1.15 million, up from $1.07 million a year ago and beating the average analyst estimate of $1.1 million. Product revenues, however, declined to $884,000 from $978,000 a year ago, a 10 percent drop. Service revenues were up 182 percent to $265,000 from $94,000 in Q4 2012.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.